Experience

University of Warwick

• United Kingdom
• Higher Education
• 700 & Above Employee

• Honorary Clinical Professor

  • May 2015 - Present

  I have just had the great honor of being appointed as a honorary chair by Warwick University in recognition for my ongoing research work and support of UK science I have just had the great honor of being appointed as a honorary chair by Warwick University in recognition for my ongoing research work and support of UK science



Newcastle University

• United Kingdom
• Higher Education
• 700 & Above Employee

• Professor of Practice

  • Jun 2017 - Present

  Honorary Visiting Professor of Practice at the Civil Engineering and Geosciences Department Honorary Visiting Professor of Practice at the Civil Engineering and Geosciences Department



AstraZeneca

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• • Apr 2020 - Jun 2023

• • Apr 2019 - Jun 2023

• • Jan 1995 - Jun 2023

  I was AstraZeneca's Principal Environmental Scientist and Business Manager that coordinated the Safety Health and Environment (SHE) Research and Foresight Programmes for AstraZeneca. I provided scientific leadership on the Pharmaceuticals in the Environment issue for AstraZeneca. My specific expertise and research is focused on (i) environmental risk assessment, (ii) the biodegradation and persistence of chemicals in the environment to underpin enviornmental hazard and risk assessment, (iii) working with medicinal chemists to develop tools to assess the feasibility of greener drug design, (iv) determining the significance of antimicrobial resistance in the environment as a source of resistance for clinical infection, and (v) assessing the risks posed by medicinal products in emerging markets. I am currently co-supervising four post-doc's and six PhD students. Show less

• • Jan 1995 - Jan 1998

  Post-Doctoral Research Scientist working for the Department of the Environment and Environment Agency on the environmental relevance of standardised biodegradation test methods. This work lead to the proof of concept studies for the modified and enhanced biodegradation assays identified for persistence assessment with REACH.



NERC: Natural Environment Research Council

• United Kingdom
• Research
• 200 - 300 Employee

• • Feb 2017 - Jun 2023

  The Innovation Advisory Board (IAB) advises NERC on its strategy for strengthening the delivery of economic growth and other societal benefits (impact) from its research and innovation investments. The board helps NERC find the most effective ways to engage stakeholders, translate research and support innovation. IAB also monitors and evaluates the effectiveness and impacts of NERC innovation investments.

• • Sep 2012 - Jun 2023

  The Advisory & Implementation Group (AIG) will provide independent strategic advice on the programme research direction to the NERC Directorate and the PEB



EFPIA - European Federation of Pharmaceutical Industries and Associations

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• PIE Task Force Member

  • Jan 2015 - Jun 2023

  I represented the interests of AstraZeneca on the Efpia PIE Task Force. I led the extended ERA workstream of the Efpia Ecopharmacostewardship initiative. I also sit on the PIE Governance Committee. I represented the interests of AstraZeneca on the Efpia PIE Task Force. I led the extended ERA workstream of the Efpia Ecopharmacostewardship initiative. I also sit on the PIE Governance Committee.



ECETOC: European Centre for Ecotoxicology and Toxicology of Chemicals

• Belgium
• Research
• 1 - 100 Employee

• Scientific Committee Member

  • May 2011 - Dec 2015

  I am a technical expert for environmental fate and persistence on the ECETOC Scientific Committee. I am a technical expert for environmental fate and persistence on the ECETOC Scientific Committee.



Cardiff University / Prifysgol Caerdydd

• United Kingdom
• Higher Education
• 700 & Above Employee

• Post-Graduate Research Assistance

  • Oct 1991 - Dec 1994

  I was funded by the Defense Evaluation Research Agency to isolate bacterial capable of growing on and metabolising nitrate ester explosives and pharmaceuticals. I extracted, purified and characterised the enzymes responsible for the initial transformations of these esters I was funded by the Defense Evaluation Research Agency to isolate bacterial capable of growing on and metabolising nitrate ester explosives and pharmaceuticals. I extracted, purified and characterised the enzymes responsible for the initial transformations of these esters